For experiments assessing pMHC-specific CTLs on AML cells, we generated CTLs targeting the HLA-A*02:01-restricted 9 amino acid peptide RMFPNAPYL from the protein WT1. The gene discussed is HLA-A; the disease is acute myeloid leukemia.